Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 53.39%
March 31, 2026 49.08%
December 31, 2025 49.28%
September 30, 2025 54.36%
June 30, 2025 50.65%
March 31, 2025 48.06%
December 31, 2024 45.32%
September 30, 2024 54.93%
June 30, 2024 53.12%
March 31, 2024 42.86%
December 31, 2023 37.10%
September 30, 2023 48.24%
June 30, 2023 45.78%
March 31, 2023 44.92%
December 31, 2022 33.46%
September 30, 2022 44.07%
June 30, 2022 48.11%
March 31, 2022 45.20%
December 31, 2021 52.34%
September 30, 2021 59.56%
June 30, 2021 52.08%
March 31, 2021 49.28%
December 31, 2020 46.04%
September 30, 2020 54.23%
June 30, 2020 45.68%
Date Value
March 31, 2020 43.36%
December 31, 2019 42.98%
September 30, 2019 47.20%
June 30, 2019 49.69%
March 31, 2019 49.23%
December 31, 2018 50.35%
September 30, 2018 51.23%
June 30, 2018 49.85%
March 31, 2018 50.05%
December 31, 2017 48.22%
September 30, 2017 50.15%
June 30, 2017 51.24%
March 31, 2017 51.08%
December 31, 2016 48.55%
September 30, 2016 46.17%
June 30, 2016 48.04%
March 31, 2016 56.76%
December 31, 2015 49.54%
September 30, 2015 47.51%
June 30, 2015 47.29%
March 31, 2015 46.03%
December 31, 2014 47.45%
September 30, 2014 49.84%
June 30, 2014 48.47%
March 31, 2014 48.98%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Inspire Medical Systems, Inc. 85.48%
IDEXX Laboratories, Inc. 64.07%
Stryker Corp. 66.14%
Zimmer Biomet Holdings, Inc. 62.91%
Enovis Corp. 54.51%

Gross Profit Margin (Quarterly) Related Metrics